Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge

被引:41
作者
Gustavsson, Inger [1 ]
Sanner, Karin [2 ]
Lindell, Monica [4 ]
Strand, Anders [3 ]
Olovsson, Matts [2 ]
Wikstrom, Ingrid [2 ]
Wilander, Erik [1 ]
Gyllensten, Ulf [1 ]
机构
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Med Sci Dermatol & Venereol, S-75185 Uppsala, Sweden
[4] Univ Uppsala Hosp, Sect Clin Pathol & Cytol, S-75185 Uppsala, Sweden
关键词
Self-sampling; FTA cartridge; Cervical carcinoma; Human papillomavirus (HPV); Real-time polymerase chain reaction (PCR); CERVICAL-CANCER; FILTER-PAPER; SCREENING-PROGRAMS; IN-SITU; WOMEN; DNA; COLLECTION; SPECIMENS; PCR; VIRUS;
D O I
10.1016/j.jcv.2011.05.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Most procedures for self-sampling of cervical cells are based on liquid-based media for transportation and storage. An alternative is to use a solid support, such as dry filter paper media. Objectives: To evaluate if self-sampling of cervicovaginal fluid using a cytobrush (Viba-brush; Rovers Medical Devices B.V., Oss, The Netherlands) and a solid support such as the Whatman Indicating FTA (R) Elute cartridge (GE Healthcare, United Kingdom) can be used for reliable typing of human papillomavirus (HPV), as compared to cervical samples obtained by a physician using a cytobrush and the indicating FTA (R) Elute Micro card and biopsy analysis. Study design: A total of 50 women with a previous high-risk (HR) HPV positive test were invited to perform self-sampling using the Viba-brush and the FTA cartridge and thereafter a physician obtained a cervical sample using the cytobrush and a FTA card, together with a cervical biopsy for histology and HPV typing. Detection of HR-HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59 was performed using three multiplex real-time polymerase chain reaction (PCR) assays. Result: All samples contained sufficient amounts of genomic DNA and the self-samples yielded on average 3.5 times more DNA than those obtained by the physician. All women that were positive for HR-HPV in the biopsy sample also typed positive both by self-sampling and physician-obtained sampling. For women with a histological diagnosis of cervical intraepithelial neoplasia grades 2-3 (CIN 2-3) all three HPV samples showed 100% concordance. A higher number of women were HPV positive by self-sampling than by physician-obtained sampling or by biopsy analysis. Conclusion: The Viba-brush and the FTA cartridge are suitable for self-sampling of vaginal cells and subsequent HR-HPV typing. (c) 2011 Elsevier B. V. All rights reserved.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 40 条
[1]   Self-sampling versus physician-sampling for human papillomavirus testing [J].
Agorastos, T ;
Dinas, K ;
Lloveras, B ;
Font, R ;
Kornegay, JR ;
Bontis, J ;
de Sanjose, S .
INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (11) :727-729
[2]   Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden [J].
Andrae, Bengt ;
Kemetli, Levent ;
Sparen, Par ;
Silfverdal, Lena ;
Strander, Bjorn ;
Ryd, Walter ;
Dillner, Joakim ;
Tornberg, Sven .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) :622-629
[3]   Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence [J].
Arbyn, M ;
Paraskevaidis, E ;
Martin-Hirsch, P ;
Prendiville, W ;
Dillner, J .
GYNECOLOGIC ONCOLOGY, 2005, 99 (03) :S7-S11
[4]   Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs [J].
Bais, Aagje G. ;
van Kemenade, Folkert J. ;
Berkhof, Johannes ;
Verheijen, Rene H. M. ;
Snijders, Peter J. F. ;
Voorhorst, Feja ;
Babovic, Milena ;
van Ballegooijen, Marjolein ;
Helmerhorst, Theo J. M. ;
Meijer, Chris J. L. M. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) :1505-1510
[5]   Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: Proposal for new guidelines [J].
Bais, AG ;
Rebolj, M ;
Snijders, JF ;
de Schipper, FA ;
van der Meulen, DAJ ;
Verheijen, RHM ;
Voorhorst, F ;
van Ballegooijen, M ;
Meijer, CJLM ;
Helmerhorst, TJM .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (01) :122-129
[6]   Comparison of type-specific human papillomavirus data from self and clinician directed sampling [J].
Baldwin, S ;
Santos, C ;
Brown, EM ;
Nuño, T ;
Giuliano, A ;
Davis, J ;
Garcia, F .
GYNECOLOGIC ONCOLOGY, 2005, 97 (02) :612-617
[7]   Detection of cervical human papillomavirus infection in filter paper samples: a comparative study [J].
Banura, Cecily ;
Franceschi, Silvia ;
van Doorn, Leen-Jan ;
Wabwire-Mangen, Fred ;
Mbidde, Edward K. ;
Weiderpass, Elisabete .
JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 57 (02) :253-255
[9]   Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment [J].
Bekkers, RLM ;
Massuger, LFAG ;
Meijer, CJLM ;
Snijders, PJF ;
Melchers, WJG .
GYNECOLOGIC ONCOLOGY, 2006, 100 (03) :451-454
[10]   Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer [J].
Bekkers, RLM ;
Massuger, LFAG ;
Bulten, J ;
Melchers, WJG .
REVIEWS IN MEDICAL VIROLOGY, 2004, 14 (02) :95-105